BioArctic Denmark ApS: Financial statements 2025
CVR: 43775154
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BioArctic Denmark ApS (CVR 43775154) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 3,908,090 and a net result of DKK 284,133 compared with DKK 236,864 the year before. That is an increase of 21% compared with the year before. Equity in the 2025 report amounted to DKK 1,344,874. The solvency ratio was 53.5%.
- Gross Profit
- DKK 3,908,090
- Profit/Loss
- DKK 284,133
- Equity
- DKK 1,344,874
- Total Assets
- DKK 2,514,840
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 3.9M | 284K | 1.3M | 0 |
| 2024 | - | 3.2M | 237K | 842K | 2 |
| 2023 | - | 3.2M | 184K | 424K | 2 |
Official annual report
How creditworthy is BioArctic Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BioArctic Denmark ApS has published its annual report for 2024. Gross profit came to DKK 3,230,465, and the net result was DKK 236,864.
As of May 8, 2025, Emilie Hélène Ankarcrona Smith has joined the board of directors of BioArctic Denmark ApS.
As of May 8, 2025, Leif Olof Francesco Gallo has left the board of directors of BioArctic Denmark ApS.
About BioArctic Denmark ApS
BioArctic Denmark ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2023. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anna-Kaija Grönblad. The board consists of Gunilla Christina Osswald (chair), Anders Jussi Martin-Löf and Emilie Hélène Ankarcrona Smith. The company is owned by BioArctic AB. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,908,090 and a net result of DKK 284,133 compared with DKK 236,864 the year before. Equity in the 2025 report amounted to DKK 1,344,874.